By Interim Staff A new study published in Issues in Law & Medicine has found that deaths and adverse events related to the abortion pill are not being properly tracked or reported to the Food and Drug Administration (FDA), and that women who take the abortion pill mifepristone and have complications are more likely to require follow-up care at an emergency center […]
You are unauthorized to view this entire article. Please log in to your account to receive full access to The Interim.